About
Activities

Please donate

Please support us
with your donation
Donate here

Member Area
Search
Member Login

Some areas of this website are accessible to registered members only.


If you have no account yet, please click on "Register". If you have forgotten your password, please click on "Forgot login?".

Members Online
None
You are here: Home Paediatric CML Scientific Publications

Paediatric CML Publications

This is a list of scientific publications on pediatric CML. If you are aware about additional publications, please This e-mail address is being protected from spambots. You need JavaScript enabled to view it - we would be delighted to make our list more complete! Thank you!
Title Filter     Display # 
# Article Title Date
1 How I treat: childhood CML (Andolina et al, 2011) 2011
2 Imatinib Has Adverse Effect on Growth in Children With Chronic Myeloid Leukemia (Bansal 2011) 2011
3 Imatinib Is Effective in Children With Previously Untreated CML in Early Chronic Phase: Results of the French National Phase IV Trial (Millot 2011) 2011
4 CML in Children: Diagnostics and Management (Suttorp, Tauer, Millot 2011) 2011
5 Pediatric phase I trial and pharmacokinetic study of dasatinib (Aplenc, 2011) 2011
6 Distinct Impact of Imatinib on Growth at Prepubertal and Pubertal Ages of Children with CML (Shim et al, 2011) 2011
7 Controversies in treatment of CML in children and adolescents: TKI versus BMT? (Suttorp et al, 2011) 2011
8 Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia (Belgaumi et al, 2010) 2010
9 Differing Age Patterns in Chronic Myeloid Leukemia (CML) by Racial Ethnic Group (Levine at al, 2010) 2010
10 Treatment of Pediatric CML in 2010: Use of Tyrosine Kinase Inhibitors and Stem Cell Transplantation (Suttorp et al, 2010) 2010
11 Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia (Haruko Shima et al, 2010) 2010
12 Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia (Asim Belgaumi et al, 2009) 2009
13 Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program (Muramatsu et al, 2009) 2009
14 Impact of imatinib on the in vitro osteoclastogenic differentiation of monocytes in children and adolescents with chronic myeloid leukemia (Jaeger, 2009) 2009
15 Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I (Suttorp et al, 2009) 2009
16 Molecular response of pediatric chronic myeloid leukemia (CML) with imatinib mesylate therapy (Basak, 2008) 2008
17 Prognosis of pediatric patients transplanted for Ph+ chronic myeloid leukemia in the period from 1989 to 2006 in the Czech Republic (Krol, 2008) 2008
18 Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia (Millot, 2005) 2005
19 Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy? (Pulsipher, 2004) 2004
20 Early blastic transformation following complete cytogenetic response in a pediatric chronic myeloid leukemia patient treated with imatinib mesylate (Morimoto) 2004
21 Stem cell transplantation for chronic myeloid leukemia in children (Cwynarski 2003) 2003
22 Build it and they will come (or will they?) (Casper, 2003) 2003
23 Stem cell transplantation for chronic myeloid leukemia in children (Cwynarski, 2003) 2003
 

© iCMLf International Chronic Myeloid Leukemia Foundation